And now for the dirt. I am doing an armature re

And now for the dirt.

I am doing an armature research on Big Pharma and FDA. Here's a few pieces that might have some educational value for long time investors in CYDY.


The Biopharmaceutical Industry Provides 75% Of The FDA's Drug Review Budget. Is This A Problem?

Insert-tag-here
https://www.forbes.com/sites/johnlamattina/20...4036e649ec



Investigation Examines Big Pharma Payments to FDA Advisers
https://www.biospace.com/article/investigatio...-advisers/

Majority of doctors who oversee FDA drug approval receive payments from companies they monitor, report shows

Insert-tag-here
https://www.independent.co.uk/news/world/amer...33621.html



The Evils of Big Pharma Exposed
Plenty of empirical evidence exists that confirm concerted diabolical efforts have been made to ruin the lives of pioneering heroes who have come up with possible cures for cancer, AIDS and other terminal illnesses. Obviously their work poses a serious threat to medical status quo. Hence, their treatments have all been effectively suppressed by conventional medicine. Bottom line, if humans are healthy, the healthcare industry does not survive. Thus, it’s in its own inherently self-serving interest to promote illness in the name of wellness.

Insert-tag-here
https://www.globalresearch.ca/the-evils-of-bi...ed/5425382



Alexandria Ocasio-Cortez Stands Up to Big Pharma
https://www.youtube.com/watch?v=HIQk5B0il-A

Hidden conflicts? Pharma payments to FDA advisers after drug approvals spark ethical concerns

Insert-tag-here
https://www.sciencemag.org/news/2018/07/hidde...rk-ethical


FDA's Scott Gottlieb Calls Out Big Pharma On Blocking Competition
Insert-tag-here
https://www.youtube.com/watch?v=9-qnuNvYNHo


FDA commissioner Scott Gottlieb is resigning
Insert-tag-here
https://www.youtube.com/watch?v=N3CFCG4kUuc


from Investopedia: What Are Barriers to Entry for Pharma Companies?
Intellectual Property Challenges

Intellectual property hurdles are substantial for two reasons. First, patents are often taken out to use as legal weapons by huge companies to fight off their competitors even if they do not plan on completing trials for the drug. Second, legitimate patents are risky because they might run out, and often do, before the FDA approves the prescription, essentially creating a patent cliff from the get-go.

BIG PHARMA’S ROLE IN CLINICAL TRIALS

Insert-tag-here

https://www.drugwatch.com/featured/clinical-t...dden-data/

Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.